{
  "id": "ff542cac1db1903d",
  "title": "Clinical Trial Holds Cast Doubt on Approval Chances of Regenxbio Gene Therapy for Rare Disease",
  "description": "20260201T150000Z",
  "content": "",
  "source": "medcitynews.com",
  "source_url": "https://medcitynews.com/2026/02/clinical-trial-hold-regenxbio-gene-therapy-hurler-hunter-syndrome-mps-rare-disease-rgnx/",
  "published_at": "20260201T150000Z",
  "fetched_at": "2026-02-02T00:29:20.107852+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "gene therapy"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://medcitynews.com/2026/02/clinical-trial-hold-regenxbio-gene-therapy-hurler-hunter-syndrome-mps-rare-disease-rgnx/",
    "url_mobile": "",
    "title": "Clinical Trial Holds Cast Doubt on Approval Chances of Regenxbio Gene Therapy for Rare Disease",
    "seendate": "20260201T150000Z",
    "socialimage": "https://medcitynews.com/wp-content/uploads/sites/7/2021/03/GettyImages-1227710766.jpg",
    "domain": "medcitynews.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}